Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name 177Lu-PSMA-617
Trade Name
Synonyms Lu177-PSMA-617|Vipivotide tetraxetan Lu-177
Drug Descriptions

177Lu-PSMA-617 is a radioconjugate comprising a PSMA inhibitor radiolabeled with Lu177, which targets PSMA expressing cells, potentially resulting in decreased tumor growth (PMID: 25883127, PMID: 26795286, PMID: 32823294, PMID: 32760622).

DrugClasses
CAS Registry Number 1703749-62-5
NCIT ID C148145

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
177Lu-J591 + 177Lu-PSMA-617 177Lu-J591 177Lu-PSMA-617 0 1
177Lu-PSMA-617 177Lu-PSMA-617 0 5
177Lu-PSMA-617 + Abemaciclib 177Lu-PSMA-617 Abemaciclib 0 1
177Lu-PSMA-617 + Pembrolizumab 177Lu-PSMA-617 Pembrolizumab 0 1


Additional content available in CKB BOOST